Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The aim of the REFRACT clinical trial is to find new therapies with improved outcomes compared to the current standard treatment available, in patients with relapsed or refractory follicular lymphoma. This will be done by comparing patients who have received a new treatment against patients who receive standard treatment based on their response to the treatment received.
Epistemonikos ID: 89e6cb20d9b3eb1a2f56433b824a2f71ca0e7137
First added on: Feb 19, 2024